Cluster randomised controlled trial to examine medical mask use as source control for people with respiratory illness by Abrar Ahmad Chughtai, Chandini Raina MacIntyre, Yi Zhang, Quanyi Wang, Bayzidur Rahman, Haiyan Zhang, Holly Seale, Daitao Zhang, Yanhui Chu

“…Since 43 index cases in the control arm also used a mask during the study period, an as-treated post hoc analysis was performed by comparing outcomes among household members of index cases who used a mask (mask group) with household members of index cases who did not use a mask (no-mask group).Main outcome measure Primary outcomes measured in household members were clinical respiratory illness, ILI and laboratory-confirmed viral respiratory infection.Results In an intention-to-treat analysis, rates of clinical respiratory illness (relative risk (RR) 0.61, 95% CI 0.18 to 2.13), ILI (RR 0.32, 95% CI 0.03 to 3.13) and laboratory-confirmed viral infections (RR 0.97, 95% CI 0.06 to 15.54) were consistently lower in the mask arm compared with control, although not statistically significant. …”
Get full text

Multiple viral infections and antimicrobial use in hospitalized children with respiratory illness during pandemic and early post-pandemic era, Taiwan by Chyi-Liang Chen, Yi-Ching Chen, Hsuan-Ling Hsiao, Yi-Jung Chang, Hsin-Chieh Li, Merve Arslan Aydin, Cheng-Hsun Chiu

Subjects: Get full text

Equine Herpesvirus-1 Induced Respiratory Disease in Dezhou Donkey Foals: Case Study from China, 2024 by Lian Ruan, Liangliang Li, Rongze Yang, Anrong You, Muhammad Zahoor Khan, Yue Yu, Li Chen, Yubao Li, Guiqin Liu, Changfa Wang, Tongtong Wang

Subjects: “…respiratory illness…”
Get full text

Breathing time: a longue-durée multidisciplinary study of respiratory illnesses and airborne diseases in Switzerland (16th–21st century CE) by Tobias Hofstetter, Aude Fauvel, Silke Grabherr, Negahnaz Moghaddam

“…This research is the first of its kind to assess of the impact of respiratory illnesses and airborne diseases (acronymized as “RIAD” hereafter) on Swiss mortality in the long run, between the 16th and the 21st century CE. …”
Get full text

Immunogenetic Factors Associated with Severe Respiratory Illness Caused by Zoonotic H1N1 and H5N1 Influenza Viruses by Jennifer Juno, Keith R. Fowke, Yoav Keynan

“…An understanding of the host genetic determinants of susceptibility and severe respiratory illness, however, is currently lacking. By better defining the role of genetic variability in influenza infection and identifying key polymorphisms that impair the host immune response or correlate with protection, we will be able to better identify at-risk populations and new targets for therapeutic interventions and vaccines. …”
Get full text

Description of a Current Outbreak of <i>Mycoplasma pneumoniae</i> in the United States by Anupama Raghuram, Stephen Furmanek, Thomas Chandler, Salwa Rashid, William Mattingly, Julio Ramirez

Subjects: Get full text

Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study by Molly Moore Jeffery, Lucas Oliveira J e Silva, Fernanda Bellolio, Nathan W Cummins, Timothy M Dempsey, Vesna D Garovic, Andrew Limper

“…Objectives Evaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute viral respiratory illness (AVRI) due to COVID-19.Design Retrospective cohort.Setting The USA; 2017–2018 influenza season, 2018–2019 influenza season, and 2019–2020 influenza/COVID-19 season.Participants People with hypertension (HTN) taking an ACEi, ARB or other HTN medications, and experiencing AVRI.Main outcome measures Change in hospital admission, intensive care unit (ICU) or coronary care unit (CCU), acute respiratory distress (ARD), ARD syndrome (ARDS) and all-cause mortality, comparing COVID-19 to pre-COVID-19 influenza seasons.Results The cohort included 1 059 474 episodes of AVRI (653 797 filled an ACEi or ARB, and 405 677 other HTN medications). 58.6% were women and 72.9% with age ≥65. …”
Get full text

Adenoviral infection in children admitted with severe acute respiratory infection at tertiary care hospital from North India: A case series by Rajarshi Bera, Pallavi Pallavi, Sonal Saxena, Shashi Chawla, Urmila Jhamb, Romit Saxena

Subjects: Get full text

Injury and Illness in Elite Athletics: A Prospective Cohort Study Over Three Seasons by Shane Kelly, Noel Pollock, George Polglass, Ben Clarsen

“…Hamstring muscle strain was the most common diagnosis causing time loss, followed by Achilles tendinopathy and soleus muscle strain. Respiratory illness was the most common illness type (0.3 per athlete year)…”
Get full text

Influenza Infection Screening Tools Fail to Accurately Predict Influenza Status for Hospitalized Patients During Pandemic H1N1 Influenza Season by Sunita Mulpuru, Virginia R Roth, Nadine Lawrence, Alan J Forster

“…BACKGROUND: Following the severe acute respiratory syndrome outbreak in 2003, hospitals have been mandated to use infection screening questionnaires to determine which patients have infectious respiratory illness and, therefore, require isolation precautions. …”
Get full text

Laboratory Diagnosis of Chlamydia Pneumoniae Infections by Rosanna W Peeling

“…Chlamydia pneumoniae is an important cause of respiratory illness. There is a need for accurate and rapid laboratory diagnostic methods that will lead to improved patient care, appropriate use of antimicrobial therapy and a better understanding of the epidemiology of this emerging pathogen. …”
Get full text

Hantavirus Pulmonary Syndrome: Report of the First Canadian Paediatric Case by Bonita E Lee, Ari R Joffe, Wendy Vaudry

“…Hantavirus pulmonary syndrome (HPS) was first recognized as a severe respiratory illness transmitted through rodent excreta in the southwestern United States in 1993. …”
Get full text

Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient by Sam K. Touisserkani, Azin Ayatollahi

“…Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. …”
Get full text

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19 by Monarch Shah, John Paul Colombo, Sanya Chandna, Haris Rana

“…COVID-19 is a respiratory illness that affects the human body in many different ways. …”
Get full text

Preventing Foodborne Illness: Norovirus by Keith R. Schneider, Renée M. Goodrich, Michael J. Mahovic, Rajya Shukla

“…Norovirus, similar to Norwalk virus, causes an illness called gastroenteritis, which is commonly referred to as “the stomach flu” (no relation to the common flu, which is a respiratory illness caused by the influenza virus).  This document is FSHN05-18, one of a series of the Food Science and Human Nutrition Department, UF/IFAS Extension. …”
Get full text

Learning from Mistakes by LE Nicolle

“…In the present issue of the Journal, Patrick and his colleagues (pages 330-336) describe an episode in the summer of 2003, immediately following the severe acute respiratory syndrome (SARS) epidemic, when an outbreak of respiratory illness occurred in a long-term care facility in Vancouver, and was initially reported by the National Microbiology Laboratory (NML) to be SARS. …”
Get full text

Preventing Foodborne Illness: Norovirus by Keith R. Schneider, Renée M. Goodrich, Michael J. Mahovic, Rajya Shukla

“…Norovirus, similar to Norwalk virus, causes an illness called gastroenteritis, which is commonly referred to as “the stomach flu” (no relation to the common flu, which is a respiratory illness caused by the influenza virus).  This document is FSHN05-18, one of a series of the Food Science and Human Nutrition Department, UF/IFAS Extension. …”
Get full text

Ethical Considerations regarding the Withdrawal of Life Support: Analysis of a Case by Melany Yamilex Reascos Chalacán, Mauricio Fernando Enrríquez Grijalva, Denisse Isabel Suaste Pazmiño

“…A clinical case is presented in which the patient was in a delicate health situation due to a serious respiratory illness for which he was kept on life support. …”
Get full text

Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective by Nusrat Homaira, William Rawlinson, Thomas L. Snelling, Adam Jaffe

“…Palivizumab, a humanized monoclonal antibody, has been recommended for high risk infants to prevent severe RSV-associated respiratory illness. This recommendation is based on evidence of efficacy when used under clinical trial conditions. …”
Get full text

Detecting respiratory diseases using machine learning-based pattern recognition on spirometry data by Ahmed I. Taloba, R.T. Matoog

“…The developed framework considerably improves the identification of patients' COPD and respiratory illness risk assessment.…”
Get full text